1. Home
  2. APYX vs PRQR Comparison

APYX vs PRQR Comparison

Compare APYX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.70

Market Cap

128.0M

Sector

Health Care

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.68

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
PRQR
Founded
1982
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.0M
185.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
APYX
PRQR
Price
$3.70
$1.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$6.50
$7.67
AVG Volume (30 Days)
99.6K
288.0K
Earning Date
03-10-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.22
$11.37
Revenue Next Year
$6.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$1.08
52 Week High
$4.50
$3.10

Technical Indicators

Market Signals
Indicator
APYX
PRQR
Relative Strength Index (RSI) 52.48 50.09
Support Level $3.25 $1.65
Resistance Level $4.32 $1.80
Average True Range (ATR) 0.25 0.11
MACD 0.05 0.01
Stochastic Oscillator 59.60 39.00

Price Performance

Historical Comparison
APYX
PRQR

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: